 |
NovaBioMed IncNURTURING HEALTHIER, BETTER AND HAPPIER LIVES
|
|
Home About us Research and Development Drug Milestone Technology Business Development Investors Media Career Contact
Milestones for NovaBioMed new chemical entities.
NovaBioMed Inc is a vertically integrated company. It has novel drug delivery system develop to deliver drugs to overcome multidrug resistance (MDR) common in cancer Therapy. In addition to ovarian, breast and Non Small Cell Lung cancer treatment, our small molecules are also directed against melanoma, leukemia, and prostate
|
COMMERCIAL |
Chemical development |
Preclinical |
Phase I |
Phase II |
Phase III |
Market |
|
Anti-Cancer |
|
|
|
|
|
|
|
Certax® |
|
|
|
|
|
|
|
NBM
2001 |
|
|
|
|
|
|
|
NBM
3001 |
|
|
|
|
|
|
|
NBM
4001 |
|
|
|
|
|
|
NovaBioMed Inc copyright 2010